AADI — Aadi Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00
- $42.97m
- -$65.88m
- $24.35m
- 18
- 53
- 25
- 23
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -23.3 | -4.32 | -110 | -60.5 | -65.8 |
Depreciation | |||||
Non-Cash Items | 1.23 | 1.35 | 75.3 | 12.5 | 9.34 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.89 | -2.48 | 12.2 | -1.82 | -3.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -23.9 | -5.38 | -22.4 | -49.6 | -59.7 |
Capital Expenditures | -0.237 | -0.019 | -0.046 | -0.444 | -3.97 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | 25.2 | -132 | 87.2 |
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.237 | -0.019 | 25.2 | -133 | 83.2 |
Financing Cash Flow Items | 0 | -0.403 | -9.62 | -0.659 | -0.16 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0 | 9.48 | 142 | 72.6 | 0.326 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -24.1 | 4.08 | 145 | -110 | 23.9 |